Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · IEX Real-Time Price · USD
1.350
+0.180 (15.38%)
At close: Jul 26, 2024, 3:58 PM
1.360
+0.010 (0.74%)
After-hours: Jul 26, 2024, 7:56 PM EDT
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $3.24 million as of July 26, 2024. Its market cap has decreased by -46.95% in one year.
Market Cap
3.24M
Enterprise Value
-1.69M
1-Year Change
-46.95%
Ranking
Category
Stock Price
$1.35
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $56.87M to $3.24M, a decrease of -94.31%. That is a compound annual growth rate of -75.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 26, 2024 | 2.50M | 8.70% |
| Dec 29, 2023 | 2.30M | -72.29% |
| Dec 30, 2022 | 8.30M | -85.41% |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cingulate | 3.69M |
| Bio-Path Holdings | 3.68M |
| Healthcare Triangle | 3.65M |
| Tharimmune | 3.55M |
| Ensysce Biosciences | 3.25M |
| ZyVersa Therapeutics | 3.21M |
| Xylo Technologies | 3.17M |
| Aptevo Therapeutics | 3.17M |